Flagship explainer
What drives KYNTRA BIO, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $183M | FY2025 |
| |
| Income before tax | −$58.3M | FY2025 |
|
| Operating income | −$45.9M | FY2025 |
|
| $6.4M | FY2025 |
| |
| Ending assets | $120M | FY2025 |
|
| Beginning assets | $215M | FY2024 |
|
| −$30M | FY2025 |
| |
| −$226M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-108346